VEGF Receptor 2 Kinase Inhibitor I(210303-54-1)
- Name: VEGF Receptor 2 Kinase Inhibitor I
- Synonyms:15966-93-5;VEGF Receptor 2 Kinase Inhibitor I;VEGFR2 Kinase Inhibitor I;SU5408;Vegfr 2 kinase inhibitor I;Vegfr-2 inhi;CHEMBL86943;U07H877HUF;ethyl 2,4-dimethyl-5-[(Z)-(2-oxo-1H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxylate;SU 5408;VEGFR2 kinase inhibitor I(SU-5408);1H-Pyrrole-3-carboxylic acid, 5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-, ethyl ester;3-(2,4-dimethyl-3-ethoxycarbonylpyrrol-5-methylidenyl)-2-indolinone;Ethyl 2,4-dimethyl-5-(((3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene)methyl)-1H-pyrrole-3-carboxylate;ethyl 2,4-dimethyl-5-{[(3Z)-2-oxo-2,3-dihydro-1H-indol-3-ylidene]methyl}-1H-pyrrole-3-carboxylate;D07OSK;K00004;UNII-U07H877HUF;SCHEMBL378979;GTPL6053;HMS3229O05;BDBM50065308;HSCI1_000034;AKOS037515527;CCG-206803;CS-7523;HY-103002;S6514;C73016;J-009628;Q27089130;(Z )-3-[(2,4-dimethyl-3-(ethoxycarbonyl)pyrrol-5-yl)methylidenyl]indolin-2-one;(Z)-ethyl 2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrole-3-carboxylate;{(Z)-3-[(2,4-Dimethyl-3-(ethoxycarbonyl)pyrrol-5-yl)methylidenyl]indolin-2-one;ethyl (Z)-2,4-dimethyl-5-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrole-3-carboxylate;(Z)-3-[(2,4-Dimethyl-3-(ethoxycarbonyl)pyrrol-5-yl)methylidenyl]indolin-2-one;2,4-Dimethyl-5-[2-oxo-1,2-dihydro-indol-(3Z)-ylidenemethyl]-1H-pyrrole-3-carboxylic acid ethyl ester;210303-54-1
- Molecular Formula:C18H18N2O3
- Molecular Weight:310.3
- CAS Registry Number:210303-54-1
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 956796-14-8/N-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-6-[4-[(2E)-3-phenyl-2-propen-1-yl]-1-piperazinyl]-3-pyridazinamine
- 851903-67-8/N-(1,1-Dimethylethyl)-4-[2-(5H-1,2,4-triazino[6,5-b][1,4]benzothiazin-3-ylthio)acetyl]-1-piperazineacetamide
- 851208-27-0/2-[(5,6-diphenyl-1,2,4-triazin-3-yl)sulfanyl]-N-(oxolan-2-ylmethyl)propanamide
- 851789-48-5/3-(2-Oxolanylmethylthio)-5,6-diphenyl-1,2,4-triazine
- 674788-30-8/6-(2,3-Dichlorophenyl)-3-(methylsulfanyl)-6,7-dihydro[1,2,4]triazino[5,6-d][3,1]benzoxazepine
- 696646-62-5/6-chloro-3-[(5,6-diphenyl-1,2,4-triazin-3-yl)sulfanyl]-4-phenylquinolin-2(1H)-one
- 5619-91-0/N-[(Z)-(2,4-dimethoxyphenyl)methylideneamino]-6-methyl-5H-[1,2,4]triazino[5,6-b]indol-3-amine
- 823211-50-3/Methyl 2-(2-((5,6-di(furan-2-yl)-1,2,4-triazin-3-yl)thio)acetamido)-4,5-dimethylthiophene-3-carboxylate
- 626223-65-2/N-(2-methoxyethyl)-2-((6-(p-tolyl)pyridazin-3-yl)thio)acetamide
- 507473-23-6/1H-1,2,4-Triazolo[4,3-b]pyridazin-4-ium, 8-hydroxy-1,6-dimethyl-, inner salt
- 890091-56-2/2-[(1H-1,2,3-Benzotriazol-4-ylamino)methyl]-6-methoxyphenol
- 890091-91-5/2-[(1H-benzotriazol-6-ylamino)methyl]-6-methoxyphenol
- 6711-41-7/2-[(8-methoxy-5H-[1,2,4]triazino[5,6-b]indol-3-yl)sulfanyl]ethyl-dimethylazanium
- 6998-57-8/decyl 2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylsulfanyl)acetate
- 6464-14-8/10-Bromo-6-(3-chloro-5-ethoxy-4-phenylmethoxyphenyl)-3-prop-2-enylsulfanyl-6,7-dihydro-[1,2,4]triazino[5,6-d][3,1]benzoxazepine
- 7241-70-5/Agn-PC-0LT9QW
- 35987-48-5/2-[4-(5-Methyl-[1,2,4]triazino[5,6-b]indol-3-yl)piperazin-1-yl]ethanol
- 32248-36-5/5-(1-Piperidinyl)-4-(1-piperidinylmethyl)-2,3-pentanedione 2-oxime
- 1956296-96-0/Syk Inhibitor
- 210303-54-1/VEGF Receptor 2 Kinase Inhibitor I
- 30259-25-7/4-Anilinobenzenediazonium;formaldehyde;hydrogen sulfate
- 1217495-65-2/Aconitine crystalline
- 7633-71-8/Remerine hydrochloride
- 5187-74-6/Hexamethonium bromide dihydrate
- 1314902-72-1/2-Amino-2-methoxy-1,3-propanediol
- 868072-18-8/Unii-M3708K4Z4V
- 167637-45-8/Isoremoxipride C-11
- 959312-46-0/Oxalic acid, allyl dodecyl ester
- 959312-47-1/Allyl octadecyl oxalate
- 959312-54-0/Oxalic acid, monoamide, N-allyl-, propyl ester